These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24662035)

  • 1. Considering a new paradigm for Alzheimer's disease research.
    Langley GR
    Drug Discov Today; 2014 Aug; 19(8):1114-24. PubMed ID: 24662035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research.
    Langley G; Austin CP; Balapure AK; Birnbaum LS; Bucher JR; Fentem J; Fitzpatrick SC; Fowle JR; Kavlock RJ; Kitano H; Lidbury BA; Muotri AR; Peng SQ; Sakharov D; Seidle T; Trez T; Tonevitsky A; van de Stolpe A; Whelan M; Willett C
    Environ Health Perspect; 2015 Nov; 123(11):A268-72. PubMed ID: 26523530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.
    Flood DG; Marek GJ; Williams M
    Biochem Pharmacol; 2011 Jun; 81(12):1422-34. PubMed ID: 21295552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying systems biology in drug discovery and development.
    Galizzi JP; Lockhart BP; Bril A
    Drug Metabol Drug Interact; 2013; 28(2):67-78. PubMed ID: 23612649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease.
    Geerts H; Spiros A; Roberts P; Carr R
    Eur J Pharmacol; 2017 Dec; 817():38-45. PubMed ID: 28583429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.
    Bales KR
    Expert Opin Drug Discov; 2012 Apr; 7(4):281-97. PubMed ID: 22458501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non human primate models for Alzheimer's disease-related research and drug discovery.
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2017 Feb; 12(2):187-200. PubMed ID: 27960560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative approach to drug discovery for Alzheimer's disease dementia.
    Schubert D; Maher P
    Future Med Chem; 2012 Sep; 4(13):1681-8. PubMed ID: 22924506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 14. Systems biology in drug discovery and development.
    Berg EL
    Drug Discov Today; 2014 Feb; 19(2):113-25. PubMed ID: 24120892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 16. Can cloud-based tools accelerate Alzheimer's disease drug discovery?
    Cacabelos R; Teijido O; Carril JC
    Expert Opin Drug Discov; 2016; 11(3):215-23. PubMed ID: 26766514
    [No Abstract]   [Full Text] [Related]  

  • 17. A Human-Based Integrated Framework for Alzheimer's Disease Research.
    Pistollato F; Cavanaugh SE; Chandrasekera PC
    J Alzheimers Dis; 2015; 47(4):857-68. PubMed ID: 26401764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery.
    Uliassi E; Gandini A; Perone RC; Bolognesi ML
    Future Med Chem; 2017 Jun; 9(10):995-1013. PubMed ID: 28632448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of Alzheimer's disease and drug development.
    Laurijssens B; Aujard F; Rahman A
    Drug Discov Today Technol; 2013 Sep; 10(3):e319-27. PubMed ID: 24050129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.